Reuters Editor-in-Chief Alessandra Galloni interviews Pfizer CEO Albert Bourla, a 30-year Pfizer veteran and CEO since 2019, at 12:15 p.m. ET on May 11. Pfizer, one of the world’s largest pharmaceutical companies, is the world’s largest supplier of COVID-19 vaccines and the most successful anti-viral therapeutic on the market. Disclosure: Thomson Reuters Foundation Chairman James Smith…
LIVE 12:15 PM ET: Reuters Interviews Pfizer CEO Albert Bourla
May 11, 2023
admin
Albert BourlaAlessandra GalloniCOVID-19EpochTVEpochTV LiveLive VideosPfizer CEOReuters Editor-in-ChiefUSUS NewsVideo
0 Comment
LIVE NOW: Reuters Interviews Pfizer CEO Albert Bourla
May 11, 2023
admin
Albert BourlaAlessandra GalloniCOVID-19EpochTVEpochTV LiveLive VideosPfizer CEOReuters Editor-in-ChiefUSUS NewsVideo
0 Comment
Reuters Editor-in-Chief Alessandra Galloni interviews Pfizer CEO Albert Bourla, a 30-year Pfizer veteran and CEO since 2019, at 12:15 p.m. ET on May 11. Pfizer, one of the world’s largest pharmaceutical companies, is the world’s largest supplier of COVID-19 vaccines and the most successful anti-viral therapeutic on the market. Disclosure: Thomson Reuters Foundation Chairman James Smith…
Reuters Interviews Pfizer CEO Albert Bourla
May 11, 2023
admin
Albert BourlaAlessandra GalloniCOVID-19EpochTVEpochTV LiveLive VideosPfizer CEOReuters Editor-in-ChiefUSUS NewsVideo
0 Comment
Reuters Editor-in-Chief Alessandra Galloni interviews Pfizer CEO Albert Bourla, a 30-year Pfizer veteran and CEO since 2019, at 12:15 p.m. ET on May 11. Pfizer, one of the world’s largest pharmaceutical companies, is the world’s largest supplier of COVID-19 vaccines and the most successful anti-viral therapeutic on the market. Disclosure: Thomson Reuters Foundation Chairman James Smith…
Pfizer Plans to Hike Price of US COVID-19 Vaccine by 400 Percent
October 21, 2022
admin
Booster ShotsBusiness & MarketsBusinesses in COVID-19CompaniesPfizer BioNTechPfizer CEOPfizer vaccineprice hikeUS
0 Comment
Pfizer is looking to raise the price of its COVID-19 vaccines in the United States by up to four times once Washington’s purchase program ends, according to the company’s U.S. president, Angela Lukin. Pfizer’s COVID-19 vaccine is presently provided free for all Americans by the U.S. government. Next year, when the U.S. public health emergency…
‘Global Collaboration’: Victorian Government in Agreement with Pfizer
March 17, 2022
admin
AustraliaAustralia Labor PartyMartin Foleymonash universityPfizerPfizer CEOUniversity of MelbournevictoriaWorld
0 Comment
The Victorian state government has announced an agreement with the biopharmaceutical company Pfizer to increase “global collaboration opportunities with Victorian researchers and industry” on Mar. 18. Victoria’s minister for innovation and medical research, Jaala Pulford said that “this agreement with one of the world’s leading biopharmaceutical companies is a strong endorsement of the strength of…
Pfizer CEO Hopes for Annual COVID-19 Vaccine Over More Frequent Boosters
Albert Bourla, the CEO of Pfizer, said on Jan. 22 that he would prefer an annual COVID-19 vaccine over booster shots that are issued at more frequent intervals. In an interview with Israel’s N12 News, he was asked whether he sees booster shots being administered every four to five months on a regular basis. “This will not…
Pfizer CEO Says an Omicron-Targeted Vaccine Will Be Ready in March
Albert Bourla, the CEO of Pfizer, said a COVID-19 vaccine that specifically targets the Omicron variant of the virus as well as already circulating variants “will be ready in March.” “This vaccine will be ready in March. I don’t know how if we will need it, I don’t know how it will be used, but…
Pfizer Seeks FDA Authorization for COVID-19 Booster Shots in 16- and 17-Year-Olds
Pfizer CEO and Chairman Albert Bourla on Tuesday announced that the company and its partner BioNTech have submitted a request to the U.S. Food and Drug Administration (FDA) seeking to expand authorization for its COVID-19 booster shot for use in 16- and 17-year-olds. It comes after U.S. regulators last week expanded the eligibility for a…
Pfizer Seeks FDA Authorization for COVID-19 Booster Shots in 16-, 17-Year-Olds
Pfizer CEO and Chairman Albert Bourla on Tuesday announced that the company and its partner BioNTech have submitted a request to the U.S. Food and Drug Administration (FDA) seeking to expand authorization for its COVID-19 booster shot for use in 16- and 17-year-olds. It comes after U.S. regulators last week expanded the eligibility for a…
Pfizer CEO Predicts Vaccine-Resistant COVID-19 Variant Likely to Emerge
Pfizer CEO Albert Bourla said on Tuesday that, at some point in the future, a strain of COVID-19 that is resistant to vaccines is likely to emerge. “Every time that the variant appears in the world, our scientists are getting their hands around it,” Bourla told Fox News in an interview. “They are researching to…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta